In Vitro Diagnostics Market Research Report – Forecast to 2032

In Vitro Diagnostics Market Research Report Information By Product & Service (Reagents & Kits, Instruments, and Data management Software), By Application (Infectious Diseases, and Non-Infectious Diseases) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/MED/0659-CR | 100 Pages | Author: Kinjoll Dey | February 2021         

1 Report Prologue

2 Market Introduction

2.1 Scope of Study 21

2.2 Research Objective 21

2.3 List of Assumptions 21

2.4 Market Structure 22

3 Research Methodology

3.1 Research Process 24

3.2 Primary Research 25

3.3 Secondary Research 26

3.4 Market Size Estimation 27

3.5 Forecast Model 27

4 Market Dynamics

4.1 Introduction 29

4.2 Drivers 30

4.2.1 Rising prevalence of chronic and infectious diseases 30

4.2.2 Growing awareness of personalized medicine 31

4.2.3 Increasing adoption of point-of-care testing 32

4.2.4 Rising investments in research and development and collaborations between companies and

public organizations 32

4.3 Restraints 33

4.3.1 Unfavorable reimbursement scenario 33

4.3.2 Lack of standardization and transparency 33

4.3.3 Information and interest gap between investors and developers 33

4.4 Opportunities 34

4.4.1 Recent technological advancements have increased the appeal of in-vitro diagnostics 34

4.4.2 Developing economies provide an unserved market for in-vitro diagnostics 34

4.4.3 Growing significance of companion diagnostics 34

5 Market Factor Analysis

5.1 Porters Five Forces Analysis 36

5.1.1 Bargaining Power of Suppliers 36

5.1.2 Bargaining Power of Buyers 37

5.1.3 Threat of New Entrants 37

5.1.4 Threat of Substitutes 37

5.1.5 Intensity of Rivalry 37

5.2 Value Chain Analysis 38

5.2.1 Primary activities 38

5.2.2 Secondary Activities 38

6 In-Vitro Diagnostics Market, By Product & Services

6.1 Introduction 40

6.1.1 Reagents & Kits 41

6.1.2 Instruments 41

6.1.3 Data Management Software 41

7 In-Vitro Diagnostics Market, By Technology

7.1 Introduction 44

7.1.1 Immunoassay/Immunochemistry 45

7.1.2 Clinical Chemistry 47

7.1.3 Molecular Diagnostics 47

7.1.4 Microbiology 48

7.1.5 Hematology 48

8 In-Vitro Diagnostics Market, By Application

8.1 Introduction 50

8.1.1 Infectious Diseases 51

8.1.2 Non-Infectious Diseases 51

9 In-Vitro Diagnostics Market, By End User

9.1 Introduction 54

9.1.1 Hospitals 55

9.1.2 Laboratories 55

9.1.3 Academic Institutes 55

10 Global In-Vitro Diagnostics Market, By Region

10.1 Introduction 57

10.2 Americas 58

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.2.1 North America 62

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.2.1.1 US 66

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.2.1.2 Canada 69

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.2.2 South America 72

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.3 Europe 76

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4 Western Europe 80

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.1 Germany 84

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.2 UK 88

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.3 France 91

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.4 Spain 95

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.5 Italy 98

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.6 Rest of Western Europe 101

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.4.7 Eastern Europe 105

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5 Asia-Pacific 109

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5.1 China 113

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5.2 Japan 116

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5.3 India 119

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5.4 Australia 122

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.5.5 Rest of Asia-Pacific 126

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.6 Middle East & Africa 130

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.6.1 Middle East 134

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

10.6.2 Africa 138

In-Vitro Diagnostics Market, By Product & Services

In-Vitro Diagnostics Market, By Technology

In-Vitro Diagnostics Market, By Application

In-Vitro Diagnostics Market, By End User

11 Competitive Landscape

11.1 Competitive Scenario 143

11.1.1 Introduction 143

11.2 Company Market Share Analysis 144

11.2.1 Introduction 144

11.3 Key Developments 145

12 Company Profile

12.1 F. Hoffmann-La Roche AG 148

12.1.1 Company Overview 148

12.1.2 Financial Overview 148

12.1.3 Products & Services Offered 149

12.1.4 Key Developments 149

12.1.5 SWOT Analysis 149

12.1.6 Key Strategy 149

12.2 Abbott Laboratories 150

12.2.1 Company Overview 150

12.2.2 Financial Overview 150

12.2.3 Products & Services Offered 151

12.2.4 Key Developments 151

12.2.5 SWOT Analysis 151

12.2.6 Key Strategy 151

12.3 Siemens AG 152

12.3.1 Company Overview 152

12.3.2 Financial Overview 152

12.3.3 Products & Services Offered 153

12.3.4 Key Developments 153

12.3.5 SWOT Analysis 153

12.3.6 Key Strategy 153

12.4 Bio-Rad Laboratories, Inc. 154

12.4.1 Company Overview 154

12.4.2 Financial Overview 154

12.4.3 Products & Services Offered 155

12.4.4 Key Developments 155

12.4.5 SWOT Analysis 155

12.4.6 Key Strategy 155

12.5 Qiagen N.V. 156

12.5.1 Company Overview 156

12.5.2 Financial Overview 156

12.5.3 Products & Services Offered 157

12.5.4 Key Developments 157

12.5.5 SWOT Analysis 157

12.5.6 Key strategy 157

12.6 BioMΓ©rieux S.A. 158

12.6.1 Company Overview 158

12.6.2 Financial Overview 158

12.6.3 Products & Services Offered 159

12.6.4 Key Developments 159

12.6.5 SWOT Analysis 159

12.6.6 Key Strategy 159

12.7 Becton, Dickinson and Company 160

12.7.1 Company Overview 160

12.7.2 Financial Overview 160

12.7.3 Products & Services Offered 161

12.7.4 Key Developments 161

12.7.5 SWOT Analysis 161

12.7.6 Key Strategy 161

12.8 DiaSorin S.p.A 162

12.8.1 Company Overview 162

12.8.2 Financial Overview 162

12.8.3 Products & Services Offered 163

12.8.4 Key Developments 163

12.8.5 SWOT Analysis 163

12.8.6 Key Strategy 163

12.9 Ortho Clinical Diagnostics (Part of Johnson & Johnson Services Inc.) 164

12.9.1 Company Overview 164

12.9.2 Financial Overview 164

12.9.3 Products & Services Offered 165

12.9.4 Key Developments 165

12.9.5 SWOT Analysis 165

12.9.6 Key Strategy 165

12.10 Grifols S.A. 166

12.10.1 Company Overview 166

12.10.2 Financial Overview 166

12.10.3 Products & Services Offered 167

12.10.4 Key Developments 167

12.10.5 SWOT Analysis 167

12.10.6 Key Strategy 167

12.11 Danaher Corporation 168

12.11.1 Company Overview 168

12.11.2 Financial Overview 168

12.11.3 Products & Services Offered 169

12.11.4 Key Developments 169

12.11.5 SWOT Analysis 170

12.11.6 Key Strategy 170

12.12 Sysmex Corporation 171

12.12.1 Company Overview 171

12.12.2 Financial Overview 171

12.12.3 Products & Services Offered 172

12.12.4 Key Developments 172

12.12.5 SWOT Analysis 172

12.12.6 Key Strategy 172

12.13 Thermo Fisher Scientific 173

12.13.1 Company Overview 173

12.13.2 Financial Overview 173

12.13.3 Products & Services Offered 174

12.13.4 Key Developments 174

12.13.5 SWOT Analysis 174

12.13.6 Key Strategy 175

13 Appendix

13.1 Discussion Blue Print 177

14 List of Tables

TABLE 1 MARKET SYNOPSIS 19

TABLE 2 LIST OF ASSUMPTIONS 21

TABLE 3 PERSONALIZED THERAPY AUTHORIZED IN GERMANY 31

TABLE 4 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 40

TABLE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS & KITS, BY REGION 2023-2032 (USD MILLION) 41

TABLE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2023-2032 (USD MILLION) 41

TABLE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR DATA MANAGEMENT SOFTWARE, BY REGION 2023-2032 (USD MILLION) 41

TABLE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR SERVICES, BY REGION 2023-2032 (USD MILLION) 42

TABLE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 45

TABLE 10 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 45

TABLE 11 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 46

TABLE 12 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY REGION 2023-2032 (USD MILLION) 46

TABLE 13 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 47

TABLE 14 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION 2023-2032 (USD MILLION) 47

TABLE 15 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 47

TABLE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION 2023-2032 (USD MILLION) 48

TABLE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MICROBIOLOGY, BY REGION 2023-2032 (USD MILLION) 48

TABLE 18 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION 2023-2032 (USD MILLION) 48

TABLE 19 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 50

TABLE 20 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION 2023-2032 (USD MILLION) 51

TABLE 21 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 51

TABLE 22 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR NON-INFECTIOUS DISEASES, BY REGION 2023-2032 (USD MILLION) 52

TABLE 23 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 54

TABLE 24 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION 2023-2032 (USD MILLION) 55

TABLE 25 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY REGION 2023-2032 (USD MILLION) 55

TABLE 26 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC INSTITUTES, BY REGION 2023-2032 (USD MILLION) 55

TABLE 27 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 57

TABLE 28 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 58

TABLE 29 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 59

TABLE 30 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 59

TABLE 31 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 59

TABLE 32 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 60

TABLE 33 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 60

TABLE 34 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 60

TABLE 35 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 61

TABLE 36 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 61

TABLE 37 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 61

TABLE 38 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 62

TABLE 39 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 62

TABLE 40 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 63

TABLE 41 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 63

TABLE 42 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 63

TABLE 43 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 44 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 45 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 64

TABLE 46 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 65

TABLE 47 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 65

TABLE 48 US IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 66

TABLE 49 US IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 66

TABLE 50 US IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 51 US IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 52 US IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 53 US IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 54 US IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 68

TABLE 55 US IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 68

TABLE 56 US IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 68

TABLE 57 CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 69

TABLE 58 CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 69

TABLE 59 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 69

TABLE 60 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 70

TABLE 61 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 62 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 63 CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 71

TABLE 64 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 71

TABLE 65 CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 71

TABLE 66 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 72

TABLE 67 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 72

TABLE 68 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 73

TABLE 69 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 73

TABLE 70 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 71 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 72 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 74

TABLE 73 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 75

TABLE 74 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 75

TABLE 75 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 76

TABLE 76 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 77

TABLE 77 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 77

TABLE 78 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 77

TABLE 79 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 78

TABLE 80 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 81 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 82 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 79

TABLE 83 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 79

TABLE 84 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 79

TABLE 85 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 80

TABLE 86 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 80

TABLE 87 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 81

TABLE 88 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 81

TABLE 89 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 81

TABLE 90 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 91 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 92 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 82

TABLE 93 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 83

TABLE 94 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 83

TABLE 95 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 84

TABLE 96 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 84

TABLE 97 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 85

TABLE 98 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 85

TABLE 99 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 100 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 101 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 86

TABLE 102 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 87

TABLE 103 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 87

TABLE 104 UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 88

TABLE 105 UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 88

TABLE 106 UK IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 107 UK IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 108 UK IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 109 UK IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 110 UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 90

TABLE 111 UK IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 90

TABLE 112 UK IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 90

TABLE 113 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 91

TABLE 114 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 91

TABLE 115 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 116 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 92

TABLE 117 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 118 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 119 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 93

TABLE 120 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 94

TABLE 121 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 94

TABLE 122 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 95

TABLE 123 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 95

TABLE 124 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 95

TABLE 125 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 96

TABLE 126 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 96

TABLE 127 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 96

TABLE 128 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 97

TABLE 129 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 97

TABLE 130 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 97

TABLE 131 ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 98

TABLE 132 ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 98

TABLE 133 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 98

TABLE 134 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 135 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 136 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 137 ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 100

TABLE 138 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 100

TABLE 139 ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 100

TABLE 140 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 101

TABLE 141 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 101

TABLE 142 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 102

TABLE 143 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 102

TABLE 144 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 103

TABLE 145 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE,

2023-2032 (USD MILLION) 103

TABLE 146 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 103

TABLE 147 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE

2023-2032 (USD MILLION) 104

TABLE 148 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 104

TABLE 149 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 105

TABLE 150 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 105

TABLE 151 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 106

TABLE 152 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 106

TABLE 153 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 107

TABLE 154 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 107

TABLE 155 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 107

TABLE 156 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 108

TABLE 157 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 108

TABLE 158 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 109

TABLE 159 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 110

TABLE 160 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 110

TABLE 161 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 110

TABLE 162 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 111

TABLE 163 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 111

TABLE 164 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 111

TABLE 165 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 112

TABLE 166 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 112

TABLE 167 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 112

TABLE 168 CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 113

TABLE 169 CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 113

TABLE 170 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 113

TABLE 171 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 114

TABLE 172 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 114

TABLE 173 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 114

TABLE 174 CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 115

TABLE 175 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 115

TABLE 176 CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 115

TABLE 177 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 116

TABLE 178 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 116

TABLE 179 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 116

TABLE 180 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 117

TABLE 181 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 117

TABLE 182 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 117

TABLE 183 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 118

TABLE 184 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 118

TABLE 185 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 118

TABLE 186 INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 119

TABLE 187 INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 119

TABLE 188 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 119

TABLE 189 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 120

TABLE 190 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 120

TABLE 191 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 120

TABLE 192 INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 121

TABLE 193 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 121

TABLE 194 INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 121

TABLE 195 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 122

TABLE 196 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 122

TABLE 197 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 123

TABLE 198 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 123

TABLE 199 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 124

TABLE 200 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 124

TABLE 201 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 124

TABLE 202 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 125

TABLE 203 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 125

TABLE 204 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 126

TABLE 205 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 126

TABLE 206 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 127

TABLE 207 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 127

TABLE 208 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 128

TABLE 209 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 128

TABLE 210 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 128

TABLE 211 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 129

TABLE 212 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 129

TABLE 213 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 130

TABLE 214 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 131

TABLE 215 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 131

TABLE 216 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2023-2032 (USD MILLION) 131

TABLE 217 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 132

TABLE 218 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 132

TABLE 219 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 132

TABLE 220 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 133

TABLE 221 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 133

TABLE 222 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 133

TABLE 223 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 134

TABLE 224 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 134

TABLE 225 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 135

TABLE 226 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2023-2032 (USD MILLION) 135

TABLE 227 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 136

TABLE 228 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 136

TABLE 229 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 136

TABLE 230 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 137

TABLE 231 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 137

TABLE 232 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 138

TABLE 233 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 138

TABLE 234 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 139

TABLE 235 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 139

TABLE 236 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 140

TABLE 237 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 140

TABLE 238 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 140

TABLE 239 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 141

TABLE 240 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 141

TABLE 241 GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY DEVELOPMENT 145

15 List of Figures

FIGURE 1 GLOBAL IN-VITRO DIAGNOSTICS MARKET: MARKET STRUCTURE 22

FIGURE 2 RESEARCH PROCESS OF MRFR 24

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 27

FIGURE 4 VALUE CHAIN 38

FIGURE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2020 & 2027 (USD MILLION) 40

FIGURE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2020 & 2027 (USD MILLION) 44

FIGURE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 50

FIGURE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2020 & 2027 (USD MILLION) 54

FIGURE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2020 & 2027 (USD MILLION) 57

FIGURE 10 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION COUNTRY 2020 (%) 58

FIGURE 11 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 62

FIGURE 12 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2020 (%) 76

FIGURE 13 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 80

FIGURE 14 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 109

FIGURE 15 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 130

FIGURE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (%) 143

FIGURE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET, MARKET SHARE ANALYSIS 2020 (%) 144

In Vitro Diagnostics Market Segmentation


In Vitro Diagnostics Product & Service Outlook (USD Billion, 2018-2032)




  • Reagents & Kits




  • Instruments




  • Data Management Software




In Vitro Diagnostics Application Outlook (USD Billion, 2018-2032)




  • Infectious Disease




  • Non-Infectious Disease




In Vitro Diagnostics Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • North America In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • US Outlook (USD Billion, 2018-2032)




    • US In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • US In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • CANADA In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Europe In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Germany In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • France Outlook (USD Billion, 2018-2032)




    • France In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • France In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • UK Outlook (USD Billion, 2018-2032)




    • UK In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • UK In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • ITALY In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Spain In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • REST OF EUROPE In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Asia-Pacific In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • China Outlook (USD Billion, 2018-2032)




    • China In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • China In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Japan In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • India Outlook (USD Billion, 2018-2032)




    • India In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • India In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Australia In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Rest of Asia-Pacific In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Rest of the World In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Middle East In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Africa In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America In Vitro Diagnostics by Product & service




      • Reagents & Kits




      • Instruments




      • Data Management Software






    • Latin America In Vitro Diagnostics by Application




      • Infectious Disease




      • Non-Infectious Disease







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid